Skip to main content
Smart Investors Daily
Veeva Systems Inc. logo

NYSE · VEEV

Veeva Systems Inc.

Healthcare · Medical - Healthcare Information Services

$277.20

Down-$14.28 (-5.15%)

Updated Nov 20, 2026, 1:15 AM

SID Score

6.1/10

Composite research score

Smart Money

58/100

Neutral

Market cap
37.72B
P/E ratio
43.66
Dividend yield
0.00%
52-week range
$148.05 – $325.99
Volume
2.75M
Avg. volume
1.54M

Price performance · VEEV

VEEV price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

VEEV closed at $277.20 after 20 trading sessions, down 14.06% for the selected period.

Last close
$277.20
Period change
-14.06%
Period low
$277.20
Period high
$323.04
Daily close
View OHLC price history
VEEV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$287.67$289.65$272.70$277.202.75M
Nov 17, 2026$297.76$301.00$288.081$288.411.24M
Nov 16, 2026$301.59$303.76$298.885$299.281.11M
Nov 13, 2026$305.36$305.36$299.36$301.53750.28K
Nov 12, 2026$304.77$306.50$296.80$302.42791.18K
Nov 11, 2026$309.93$311.3799$304.74$304.771.04M
Nov 10, 2026$305.60$307.65$301.7255$305.551.07M
Nov 9, 2026$303.93$308.2072$300.5901$306.401.23M
Nov 6, 2026$296.96$305.5794$294.99$303.731.75M
Nov 5, 2026$312.89$314.2299$305.1701$310.102.15M
Nov 4, 2026$306.62$312.88$302.42$310.631.44M
Nov 3, 2026$303.00$306.55$299.02$303.211.42M
Nov 2, 2026$316.20$316.20$306.92$307.001.4M
Oct 30, 2026$312.06$314.4999$309.42$312.961.38M
Oct 29, 2026$312.11$315.235$306.50$310.341.79M
Oct 28, 2026$310.00$319.00$308.50$317.821.4M
Oct 27, 2026$315.50$318.51$310.50$313.461.36M
Oct 26, 2026$323.04$325.87$316.91$318.181.12M
Oct 23, 2026$320.67$324.76$319.00$323.041.37M
Oct 22, 2026$323.99$325.99$318.03$322.551.44M

Latest VEEV news

The latest Smart Investors Daily articles mentioning VEEV.

VEEV research

Overview

Company profile and research snapshot.

Company profile

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$313.67
Implied upside
—
Analysts
40
VEEV recent ratings
DateFirmRatingTarget
Nov 11, 2026Wells FargoOverweight—
Nov 9, 2026BTIGBuy—
Nov 9, 2026Canaccord GenuityHold—
Nov 9, 2026Truist SecuritiesBuy—
Nov 6, 2026Evercore ISI GroupIn-Line—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 12, 2026

Veeva to Release Fiscal 2027 Third Quarter Results on December 3, 2026

Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter ending October 31, 2026 after market close on December 3, 2026. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.